People-Centric, Innovation-Driven

MicroPort® is all about improving human life through the practical application of innovative science. Our aim is to continually develop leading technologies and products for physicians, with life-saving solutions and treatments for patients.

hospitals
Over 10,000

hospitals covered globally

market
300

products released to the market

Hospital
Over 6,000

employees from over 30 countries

The Patient Always Comes First.

MicroPort® constantly adheres to a people-centric approach to build a leading and globalized healthcare group, where the patient always comes first, in the area of high-technology therapies represented by minimal invasion.

Clinical Solutions

Cure diseases, heal patients

More

Patient Care

Heartfelt care, handholding journey

More

Innovation Windows

More innovation for the industry. We never stop.

More

Leading Total Medical Solutions Provider

Thus far, MicroPort® has released about 300 products to the market, covering 10 major business segments, including Cardiovascular Intervention & Structural Heart Diseases, Electrophysiology & Cardiac Rhythm Management, Orthopedics & Soft Tissue Repair, Endovascular & Peripheral Vascular Diseases, Neurovascular Intervention & Neurosciences, Life Sciences (Endocrine Management), Surgical Devices & Medical Robotics, Urology & Gynecology & Respiratory & Gastroenterology, Aesthetics & Rehabilitation, and In vitro Diagnostics & Medical Imaging.

All Products

MicroPort® Global

With a head office in Zhang Jiang Science City in Shanghai, China, MicroPort® possesses a large footprint of major production and R&D facilities across the world, including Shanghai, Suzhou, Jiaxing, Dongguan in China, Memphis in the United States, Clamart in France, Saluggia in Italy, and the Dominican Republic, creating a globalized network of R&D, manufacturing, marketing, and services.